Paunovich Vukasin 4
Research Summary
AI-generated summary
LifeStance (LFST) CTO Paunovich Vukasin Receives Award of 62,935 Shares
What Happened Paunovich Vukasin, Chief Technology Officer of LifeStance Health Group (LFST), received 62,935 performance-based restricted stock units (PSUs) that vested on March 9, 2026. As part of the net settlement, 18,541 shares were withheld by the company to satisfy tax withholding obligations at $6.91 per share, equal to approximately $128,118. The award/vesting was recorded as an acquisition at $0.00 per share in the Form 4.
Key Details
- Transaction date: March 9, 2026 (reported on Form 4 filed March 11, 2026).
- Primary entry: Award/acquisition of 62,935 shares (code A) at $0.00.
- Tax withholding: 18,541 shares withheld (code F) at $6.91/share = ~$128,118.
- Footnotes: F1 — PSUs were granted June 11, 2025 and vested March 9, 2026. F2 — Withheld shares were used to satisfy tax obligations and do NOT represent an open-market sale.
- Shares owned after transaction: Not specified in the filing.
- Filing timeliness: Form 4 filed two days after the vesting date (within the standard Form 4 reporting window).
Context This was a routine compensation event (PSU vesting) rather than an open-market purchase or discretionary sale. The withholding of shares to cover taxes is a common net-settlement practice and should not be interpreted as an active sale signaling the insider’s view of the stock.